These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
860 related articles for article (PubMed ID: 36333388)
61. A Prognostic Model Using Immune-Related Genes for Colorectal Cancer. Feng W; Zhang Y; Liu W; Wang X; Lei T; Yuan Y; Chen Z; Song W Front Cell Dev Biol; 2022; 10():813043. PubMed ID: 35252182 [TBL] [Abstract][Full Text] [Related]
62. Therapeutic Benefits and Prognostic Value of a Model Based on 7 Immune-associated Genes in Bladder Cancer. Cao M; Cao Y; Xue S; Zhang Q; Zhang H; Xue W Altern Ther Health Med; 2024 Apr; 30(4):130-138. PubMed ID: 38518167 [TBL] [Abstract][Full Text] [Related]
63. Construction of an immune gene expression meta signature to assess the prognostic risk of colorectal cancer patients. Orozco-Castaño C; Mejia-Garcia A; Zambrano Y; Combita AL; Parra-Medina R; Bonilla DA; González A; Odriozola A Adv Genet; 2024; 112():207-254. PubMed ID: 39396837 [TBL] [Abstract][Full Text] [Related]
64. Immune-related gene-based prognostic index for predicting survival and immunotherapy outcomes in colorectal carcinoma. Liang Z; Sun R; Tu P; Liang Y; Liang L; Liu F; Bian Y; Yin G; Zhao F; Jiang M; Gu J; Tang D Front Immunol; 2022; 13():944286. PubMed ID: 36591255 [TBL] [Abstract][Full Text] [Related]
65. Identifying the Role of Oxidative Stress-Related Genes as Prognostic Biomarkers and Predicting the Response of Immunotherapy and Chemotherapy in Ovarian Cancer. Liu Q; Yang X; Yin Y; Zhang H; Yin F; Guo P; Zhang X; Sun C; Li S; Han Y; Yang Z Oxid Med Cell Longev; 2022; 2022():6575534. PubMed ID: 36561981 [TBL] [Abstract][Full Text] [Related]
66. Establishment of an ovarian cancer exhausted CD8+T cells-related genes model by integrated analysis of scRNA-seq and bulk RNA-seq. Hua T; Liu DX; Zhang XC; Li ST; Wu JL; Zhao Q; Chen SB Eur J Med Res; 2024 Jul; 29(1):358. PubMed ID: 38970067 [TBL] [Abstract][Full Text] [Related]
68. Unfolded protein response signature unveils novel insights into breast cancer prognosis and tumor microenvironment. Zhou N; Kong D; Lin Q; Yang X; Zhou D; Lou L; Huang F Cancer Genet; 2023 Aug; 276-277():17-29. PubMed ID: 37343507 [TBL] [Abstract][Full Text] [Related]
69. Development of a Novel Lipid Metabolism-related Gene Prognostic Signature for Patients with Colorectal Cancer. Zhan J; Cen W; Zhu J; Ye Y Recent Pat Anticancer Drug Discov; 2024; 19(2):209-222. PubMed ID: 37723964 [TBL] [Abstract][Full Text] [Related]
70. Identification and validation of mitophagy-related signatures as a novel prognostic model for colorectal cancer. Ke Q; Wang Y; Deng Y; Wang J; Yuan M; Liang A; Wang J; Gong Q Transl Cancer Res; 2024 Feb; 13(2):782-797. PubMed ID: 38482399 [TBL] [Abstract][Full Text] [Related]
71. An immune-related gene prognostic index for predicting prognosis in patients with colorectal cancer. Li C; Wirth U; Schardey J; Ehrlich-Treuenstätt VV; Bazhin AV; Werner J; Kühn F Front Immunol; 2023; 14():1156488. PubMed ID: 37483596 [TBL] [Abstract][Full Text] [Related]
72. CX3CR1 Acts as a Protective Biomarker in the Tumor Microenvironment of Colorectal Cancer. Yue Y; Zhang Q; Sun Z Front Immunol; 2021; 12():758040. PubMed ID: 35140706 [TBL] [Abstract][Full Text] [Related]
73. Risk stratification and prognosis prediction based on inflammation-related gene signature in lung squamous carcinoma. Zhai W; Chen S; Duan F; Wang J; Zhao Z; Lin Y; Rao B; Wang Y; Zheng L; Long H Cancer Med; 2023 Feb; 12(4):4968-4980. PubMed ID: 36056909 [TBL] [Abstract][Full Text] [Related]
74. Follistatin-Like 3 Correlates With Lymph Node Metastasis and Serves as a Biomarker of Extracellular Matrix Remodeling in Colorectal Cancer. Yang C; Cao F; Huang S; Zheng Y Front Immunol; 2021; 12():717505. PubMed ID: 34335633 [TBL] [Abstract][Full Text] [Related]
75. Integrative transcriptional characterization of cell cycle checkpoint genes promotes clinical management and precision medicine in bladder carcinoma. Shi WW; Guan JZ; Long YP; Song Q; Xiong Q; Qin BY; Ma ZQ; Hu Y; Yang B Front Oncol; 2022; 12():915662. PubMed ID: 36033441 [TBL] [Abstract][Full Text] [Related]
76. RNA Binding Protein-Based Model for Prognostic Prediction of Colorectal Cancer. Li T; Hui W; Halike H; Gao F Technol Cancer Res Treat; 2021; 20():15330338211019504. PubMed ID: 34080453 [TBL] [Abstract][Full Text] [Related]
77. Identification of a five-gene signature with prognostic value in colorectal cancer. Sun G; Li Y; Peng Y; Lu D; Zhang F; Cui X; Zhang Q; Li Z J Cell Physiol; 2019 Apr; 234(4):3829-3836. PubMed ID: 30132881 [TBL] [Abstract][Full Text] [Related]
78. CD4+ conventional T cells-related genes signature is a prognostic indicator for ovarian cancer. Hua T; Liu DX; Zhang XC; Li ST; Yan P; Zhao Q; Chen SB Front Immunol; 2023; 14():1151109. PubMed ID: 37063862 [TBL] [Abstract][Full Text] [Related]
79. Comprehensive analysis of prognostic immune-related genes in the tumor microenvironment of colorectal cancer. Li W; Jin X; Guo S; Xu F; Su X; Jiang X; Wang G Aging (Albany NY); 2021 Feb; 13(4):5506-5524. PubMed ID: 33536348 [TBL] [Abstract][Full Text] [Related]
80. Novel hypoxia- and lactate metabolism-related molecular subtyping and prognostic signature for colorectal cancer. Huang A; Sun Z; Hong H; Yang Y; Chen J; Gao Z; Gu J J Transl Med; 2024 Jun; 22(1):587. PubMed ID: 38902737 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]